Bone Biologics (BBLGW) Accounts Payables (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Accounts Payables for 2 consecutive years, with $740064.0 as the latest value for Q3 2017.
- Quarterly Accounts Payables rose 120.51% to $740064.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $740064.0 through Sep 2017, up 120.51% year-over-year, with the annual reading at $260149.0 for FY2016, N/A changed from the prior year.
- Accounts Payables for Q3 2017 was $740064.0 at Bone Biologics, up from $432330.0 in the prior quarter.
- The five-year high for Accounts Payables was $740064.0 in Q3 2017, with the low at $159096.0 in Q1 2017.